The Treatment of Infantile Spasms by Child Neurologists

Infantile spasms is a refractory seizure disorder for which a number of different treatment regimens are available. No information is available on which treatment regimens are most widely used and which would be of practical importance in designing clinical trials to determine efficacy of new treatm...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of child neurology 1994-10, Vol.9 (4), p.432-435
Hauptverfasser: Bobele, Gary B., Bodensteiner, John B.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 435
container_issue 4
container_start_page 432
container_title Journal of child neurology
container_volume 9
creator Bobele, Gary B.
Bodensteiner, John B.
description Infantile spasms is a refractory seizure disorder for which a number of different treatment regimens are available. No information is available on which treatment regimens are most widely used and which would be of practical importance in designing clinical trials to determine efficacy of new treatments. We proceeded to gather data on the most commonly employed methods of treating infantile spasms. A survey was mailed in 1991 to all junior, active, and emeritus members of the Child Neurology Society asking details about the treatment of infantile spasms. Telephone follow-up on a random sample of nonresponders was made. The total response rate was 58.3%. Most respondents who treat infantile spasms use corticotropin (ACTH) as their drug of first choice (88%). The most frequently used dosage was 40 IU per day, and the most frequent duration of treatment was 1 to 2 months. The most frequently reported side effects of ACTH or oral corticosteroid treatment were cushingism, behavior changes or irritability, hypertension, topical infections, and systemic infections. Of those not using ACTH, valproic acid was the next most commonly employed agent, followed by oral corticosteroids. The results were similar for all respondents regardless of age, sex, type of practice, number of cases of infantile spasms seen, location (United States or abroad) or whether the survey was completed by mail or telephone. These data suggest that there is a relative uniformity among child neurologists in the management of infantile spasms despite the publication of many alternative treatment strategies. (J Child Neurol 1994;9:432-435).
doi_str_mv 10.1177/088307389400900420
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_21206591</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sage_id>10.1177_088307389400900420</sage_id><sourcerecordid>21206591</sourcerecordid><originalsourceid>FETCH-LOGICAL-c369t-deb1259878fce2d1d2122c126f71cebdd3069cd8c27c4d7fa1df3bab1946ad03</originalsourceid><addsrcrecordid>eNp9kE1LAzEQhoMotVb_gCDk5G3tJNlukqMUPwpFD-59ySaTdst-1GT30H_vlhYvgqeBmed9YF5C7hk8MSblHJQSIIXSKYAGSDlckCmToBLFlbgk0yOQHIlrchPjDgDUQsOETKTifFxPicy3SPOApm-w7Wnn6ar1pu2rGunX3sQm0vJAl9uqdvQDh9DV3aaKfbwlV97UEe_Oc0by15d8-Z6sP99Wy-d1YkWm-8RhyfhCK6m8Re6Y44xzy3jmJbNYOicg09Ypy6VNnfSGOS9KUzKdZsaBmJHHk3Yfuu8BY180VbRY16bFbojFqINsodkI8hNoQxdjQF_sQ9WYcCgYFMeyir9ljaGHs30oG3S_kXM7431-ukezwWLXDaEdf_3P-AO_H3Fq</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>21206591</pqid></control><display><type>article</type><title>The Treatment of Infantile Spasms by Child Neurologists</title><source>MEDLINE</source><source>SAGE Complete</source><creator>Bobele, Gary B. ; Bodensteiner, John B.</creator><creatorcontrib>Bobele, Gary B. ; Bodensteiner, John B.</creatorcontrib><description>Infantile spasms is a refractory seizure disorder for which a number of different treatment regimens are available. No information is available on which treatment regimens are most widely used and which would be of practical importance in designing clinical trials to determine efficacy of new treatments. We proceeded to gather data on the most commonly employed methods of treating infantile spasms. A survey was mailed in 1991 to all junior, active, and emeritus members of the Child Neurology Society asking details about the treatment of infantile spasms. Telephone follow-up on a random sample of nonresponders was made. The total response rate was 58.3%. Most respondents who treat infantile spasms use corticotropin (ACTH) as their drug of first choice (88%). The most frequently used dosage was 40 IU per day, and the most frequent duration of treatment was 1 to 2 months. The most frequently reported side effects of ACTH or oral corticosteroid treatment were cushingism, behavior changes or irritability, hypertension, topical infections, and systemic infections. Of those not using ACTH, valproic acid was the next most commonly employed agent, followed by oral corticosteroids. The results were similar for all respondents regardless of age, sex, type of practice, number of cases of infantile spasms seen, location (United States or abroad) or whether the survey was completed by mail or telephone. These data suggest that there is a relative uniformity among child neurologists in the management of infantile spasms despite the publication of many alternative treatment strategies. (J Child Neurol 1994;9:432-435).</description><identifier>ISSN: 0883-0738</identifier><identifier>EISSN: 1708-8283</identifier><identifier>DOI: 10.1177/088307389400900420</identifier><identifier>PMID: 7822738</identifier><language>eng</language><publisher>Thousand Oaks, CA: Sage Publications</publisher><subject>Adrenal Cortex Hormones - adverse effects ; Adrenal Cortex Hormones - therapeutic use ; Adrenocorticotropic Hormone - therapeutic use ; Anticonvulsants - adverse effects ; Anticonvulsants - therapeutic use ; Dose-Response Relationship, Drug ; Drug Administration Schedule ; Humans ; Infant ; Neurology ; Spasms, Infantile - drug therapy ; United States ; Valproic Acid - adverse effects ; Valproic Acid - therapeutic use</subject><ispartof>Journal of child neurology, 1994-10, Vol.9 (4), p.432-435</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c369t-deb1259878fce2d1d2122c126f71cebdd3069cd8c27c4d7fa1df3bab1946ad03</citedby><cites>FETCH-LOGICAL-c369t-deb1259878fce2d1d2122c126f71cebdd3069cd8c27c4d7fa1df3bab1946ad03</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://journals.sagepub.com/doi/pdf/10.1177/088307389400900420$$EPDF$$P50$$Gsage$$H</linktopdf><linktohtml>$$Uhttps://journals.sagepub.com/doi/10.1177/088307389400900420$$EHTML$$P50$$Gsage$$H</linktohtml><link.rule.ids>314,776,780,21798,27901,27902,43597,43598</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/7822738$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Bobele, Gary B.</creatorcontrib><creatorcontrib>Bodensteiner, John B.</creatorcontrib><title>The Treatment of Infantile Spasms by Child Neurologists</title><title>Journal of child neurology</title><addtitle>J Child Neurol</addtitle><description>Infantile spasms is a refractory seizure disorder for which a number of different treatment regimens are available. No information is available on which treatment regimens are most widely used and which would be of practical importance in designing clinical trials to determine efficacy of new treatments. We proceeded to gather data on the most commonly employed methods of treating infantile spasms. A survey was mailed in 1991 to all junior, active, and emeritus members of the Child Neurology Society asking details about the treatment of infantile spasms. Telephone follow-up on a random sample of nonresponders was made. The total response rate was 58.3%. Most respondents who treat infantile spasms use corticotropin (ACTH) as their drug of first choice (88%). The most frequently used dosage was 40 IU per day, and the most frequent duration of treatment was 1 to 2 months. The most frequently reported side effects of ACTH or oral corticosteroid treatment were cushingism, behavior changes or irritability, hypertension, topical infections, and systemic infections. Of those not using ACTH, valproic acid was the next most commonly employed agent, followed by oral corticosteroids. The results were similar for all respondents regardless of age, sex, type of practice, number of cases of infantile spasms seen, location (United States or abroad) or whether the survey was completed by mail or telephone. These data suggest that there is a relative uniformity among child neurologists in the management of infantile spasms despite the publication of many alternative treatment strategies. (J Child Neurol 1994;9:432-435).</description><subject>Adrenal Cortex Hormones - adverse effects</subject><subject>Adrenal Cortex Hormones - therapeutic use</subject><subject>Adrenocorticotropic Hormone - therapeutic use</subject><subject>Anticonvulsants - adverse effects</subject><subject>Anticonvulsants - therapeutic use</subject><subject>Dose-Response Relationship, Drug</subject><subject>Drug Administration Schedule</subject><subject>Humans</subject><subject>Infant</subject><subject>Neurology</subject><subject>Spasms, Infantile - drug therapy</subject><subject>United States</subject><subject>Valproic Acid - adverse effects</subject><subject>Valproic Acid - therapeutic use</subject><issn>0883-0738</issn><issn>1708-8283</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1994</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kE1LAzEQhoMotVb_gCDk5G3tJNlukqMUPwpFD-59ySaTdst-1GT30H_vlhYvgqeBmed9YF5C7hk8MSblHJQSIIXSKYAGSDlckCmToBLFlbgk0yOQHIlrchPjDgDUQsOETKTifFxPicy3SPOApm-w7Wnn6ar1pu2rGunX3sQm0vJAl9uqdvQDh9DV3aaKfbwlV97UEe_Oc0by15d8-Z6sP99Wy-d1YkWm-8RhyfhCK6m8Re6Y44xzy3jmJbNYOicg09Ypy6VNnfSGOS9KUzKdZsaBmJHHk3Yfuu8BY180VbRY16bFbojFqINsodkI8hNoQxdjQF_sQ9WYcCgYFMeyir9ljaGHs30oG3S_kXM7431-ukezwWLXDaEdf_3P-AO_H3Fq</recordid><startdate>19941001</startdate><enddate>19941001</enddate><creator>Bobele, Gary B.</creator><creator>Bodensteiner, John B.</creator><general>Sage Publications</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TK</scope></search><sort><creationdate>19941001</creationdate><title>The Treatment of Infantile Spasms by Child Neurologists</title><author>Bobele, Gary B. ; Bodensteiner, John B.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c369t-deb1259878fce2d1d2122c126f71cebdd3069cd8c27c4d7fa1df3bab1946ad03</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1994</creationdate><topic>Adrenal Cortex Hormones - adverse effects</topic><topic>Adrenal Cortex Hormones - therapeutic use</topic><topic>Adrenocorticotropic Hormone - therapeutic use</topic><topic>Anticonvulsants - adverse effects</topic><topic>Anticonvulsants - therapeutic use</topic><topic>Dose-Response Relationship, Drug</topic><topic>Drug Administration Schedule</topic><topic>Humans</topic><topic>Infant</topic><topic>Neurology</topic><topic>Spasms, Infantile - drug therapy</topic><topic>United States</topic><topic>Valproic Acid - adverse effects</topic><topic>Valproic Acid - therapeutic use</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Bobele, Gary B.</creatorcontrib><creatorcontrib>Bodensteiner, John B.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Neurosciences Abstracts</collection><jtitle>Journal of child neurology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Bobele, Gary B.</au><au>Bodensteiner, John B.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The Treatment of Infantile Spasms by Child Neurologists</atitle><jtitle>Journal of child neurology</jtitle><addtitle>J Child Neurol</addtitle><date>1994-10-01</date><risdate>1994</risdate><volume>9</volume><issue>4</issue><spage>432</spage><epage>435</epage><pages>432-435</pages><issn>0883-0738</issn><eissn>1708-8283</eissn><abstract>Infantile spasms is a refractory seizure disorder for which a number of different treatment regimens are available. No information is available on which treatment regimens are most widely used and which would be of practical importance in designing clinical trials to determine efficacy of new treatments. We proceeded to gather data on the most commonly employed methods of treating infantile spasms. A survey was mailed in 1991 to all junior, active, and emeritus members of the Child Neurology Society asking details about the treatment of infantile spasms. Telephone follow-up on a random sample of nonresponders was made. The total response rate was 58.3%. Most respondents who treat infantile spasms use corticotropin (ACTH) as their drug of first choice (88%). The most frequently used dosage was 40 IU per day, and the most frequent duration of treatment was 1 to 2 months. The most frequently reported side effects of ACTH or oral corticosteroid treatment were cushingism, behavior changes or irritability, hypertension, topical infections, and systemic infections. Of those not using ACTH, valproic acid was the next most commonly employed agent, followed by oral corticosteroids. The results were similar for all respondents regardless of age, sex, type of practice, number of cases of infantile spasms seen, location (United States or abroad) or whether the survey was completed by mail or telephone. These data suggest that there is a relative uniformity among child neurologists in the management of infantile spasms despite the publication of many alternative treatment strategies. (J Child Neurol 1994;9:432-435).</abstract><cop>Thousand Oaks, CA</cop><pub>Sage Publications</pub><pmid>7822738</pmid><doi>10.1177/088307389400900420</doi><tpages>4</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0883-0738
ispartof Journal of child neurology, 1994-10, Vol.9 (4), p.432-435
issn 0883-0738
1708-8283
language eng
recordid cdi_proquest_miscellaneous_21206591
source MEDLINE; SAGE Complete
subjects Adrenal Cortex Hormones - adverse effects
Adrenal Cortex Hormones - therapeutic use
Adrenocorticotropic Hormone - therapeutic use
Anticonvulsants - adverse effects
Anticonvulsants - therapeutic use
Dose-Response Relationship, Drug
Drug Administration Schedule
Humans
Infant
Neurology
Spasms, Infantile - drug therapy
United States
Valproic Acid - adverse effects
Valproic Acid - therapeutic use
title The Treatment of Infantile Spasms by Child Neurologists
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-05T20%3A41%3A15IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20Treatment%20of%20Infantile%20Spasms%20by%20Child%20Neurologists&rft.jtitle=Journal%20of%20child%20neurology&rft.au=Bobele,%20Gary%20B.&rft.date=1994-10-01&rft.volume=9&rft.issue=4&rft.spage=432&rft.epage=435&rft.pages=432-435&rft.issn=0883-0738&rft.eissn=1708-8283&rft_id=info:doi/10.1177/088307389400900420&rft_dat=%3Cproquest_cross%3E21206591%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=21206591&rft_id=info:pmid/7822738&rft_sage_id=10.1177_088307389400900420&rfr_iscdi=true